Abiopharma

Director SCHLEIFER LEONARD S 🟡 adjusted position in 155.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $701.51 ($300.8M) Transaction Date: Dec 09, 2025 | Filing ID: 000006

Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

Kliman Gilbert H 🟡 adjusted position in 5.0K shares (1 derivative) of GLAUKOS Corp (GKOS) at $107.27 Transaction Date: Dec 09, 2025 | Filing ID: 000003

(99% Neutral) Cross Country Healthcare, Inc. (CCRN) Announces Regulatory Update

UTHR: Notification

Humer Kristian 🟢 acquired 480.0K shares (1 derivative) of 4D Molecular Therapeutics, Inc. (FDMT) at $10.51 ($5.0M) Transaction Date: Dec 09, 2025 | Filing ID: 315989

(99% Neutral) Zoetis Inc. (ZTS) Files Form 8-K

Director Hussain Abbas 🔴 sold 504 shares of Moderna, Inc. (MRNA) at $27.60 Transaction Date: Dec 09, 2025 | Filing ID: 000092

Mind Technology Inc (MIND) Files Form 10-Q

New Form SCHEDULE 13G - SciSparc Ltd. Filed: 2025-12-11 AccNo: 0001213900-25-120684 Size: 7 KB

New Form SCHEDULE 13G - SciSparc Ltd. Filed: 2025-12-11 AccNo: 0001213900-25-120685 Size: 7 KB

UTHR: Notification

(99% Neutral) NEXGEL, INC. (NXGLW) Announces Business Combination

(85% Positive) MAIA Biotechnology, Inc. (MAIA) Provides Update on confidence for ateganosine’s growing body of clinical evidence

(99% Neutral) MADRIGAL PHARMACEUTICALS, INC. (MDGL) Announces New Board Appointment